The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired commercial next-generation sequencing assays.
 
Catherine Callaghan Coombs
Honoraria - Dava Oncology; H3 Biomedicine
Travel, Accommodations, Expenses - Incyte
 
Nancy Gillis
No Relationships to Disclose
 
Kelly L Bolton
No Relationships to Disclose
 
Jonathan S. Berg
No Relationships to Disclose
 
Xianming Tan
No Relationships to Disclose
 
Michele C Hayward
No Relationships to Disclose
 
Nirali M. Patel
Employment - Q2 Solutions- Genomics Lab, Genomic Services
 
Markus Ball
No Relationships to Disclose
 
Maria Balasis
No Relationships to Disclose
 
Tania MESA
No Relationships to Disclose
 
Nathan Montgomery
Consulting or Advisory Role - Becton Dickinson (I)
Research Funding - Archer; Ventana Medical Systems
 
Kristy L. Richards
No Relationships to Disclose
 
William Y. Kim
Stock and Other Ownership Interests - BeiGene; Bristol-Myers Squibb; FibroGen; Johnson & Johnson; Kura Oncology
Honoraria - Takeda
Consulting or Advisory Role - GeneCentric
Patents, Royalties, Other Intellectual Property - BASE47 bladder cancer subtype classifier
Travel, Accommodations, Expenses - Takeda
 
David N. Hayes
Leadership - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Consulting or Advisory Role - GeneCentric
Patents, Royalties, Other Intellectual Property - I hold several diagnostic patents or pending patents in the area of solid tumor diagnostics
 
Shelton Earp
No Relationships to Disclose
 
Joel S. Parker
No Relationships to Disclose
 
Ross L. Levine
Leadership - Qiagen
Stock and Other Ownership Interests - Loxo
Honoraria - incyte
Consulting or Advisory Role - Novartis
Research Funding - Celgene; Roche
 
Elli Papaemmanuil
Employment - Tesaro (I)
Stock and Other Ownership Interests - Tesaro (I)
Honoraria - Celgene; Novartis
Speakers' Bureau - Tesaro (I)
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - My husband receives royalties for AZD5363 or AZD5393 (not sure) an AKT inhibitor through the institute of cancer research in th eUK (I)
Travel, Accommodations, Expenses - Celgene; Novartis; Tesaro (I)
 
Ahmet Zehir
No Relationships to Disclose
 
Eric Padron
Honoraria - Incyte; Karyopharm Therapeutics
Research Funding - Cell Therapeutics (Inst); Incyte (Inst)